(Nasdaq: AKAN) Obtains Key Cultivation License (4 Potential Catalysts To Know - Low Float Under 1Mn Shares)

Tell me. Were you up and ready to rock 'n' roll this morning?

StockWireNews (Nasdaq: AKAN) Obtains Key Cultivation License (4 Potential Catalysts To Know - Low Float Under 1Mn Shares) Yahoo Finance Reports (Nasdaq: AKAN) To Have A Float Of Just Over 782K Shares! October 11th Greetings Readers, Tell me. Were you up and ready to rock 'n' roll this morning? In case you missed it, my latest breakout idea turned into a viral doozy. Alerted Wednesday evening at 8:00PM EST, the Nasdaq low float alert closed after hours at $.0907. By the time the lunch bell rang on Thursday, it had surged to a mind-blowing high of $.2541 on the session. Don't look now, but that's a MASSIVE move of approximately 180% in less than 24 hours. Soak that in for a second... But, don't take too long, because here's a new breakout idea to consider... Like yesterday's Nasdaq profile, this is a low float alert with the potential for strong volatility. And "low" may be an understatement on this one. We're talking less than 1Mn shares in its float! Plus, with this company establishing itself as Europe's premium cann-a-bis ("CB") cultivator, it may just be a short matter of time until Wall Street catches on to what's going on with this company currently flying under-the-radar. Aiming to lead the way in production on the European continent, this under-the-radar Nasdaq profile needs radar consideration: *Akanda Corp. (Nasdaq: AKAN)* Akanda is an international medical cann-a-bis ("CB") and wellness platform company seeking to help people lead better lives through improved access to high quality and affordable products. And based on several potential catalysts, AKAN could have strong breakout potential. Take a look: No. 1 - A Crazy Low Float Could Lead To Explosive Volatility! No. 2 - Akanda Continues To Execute Strategic Initiative By Obtaining Key Canadian Cultivation License. No. 3 - A First-Mover Attitude Could Propel AKAN To International Recognition. No. 4 - The Addition Of Block-chain And AI Solutions Could Separate AKAN From The Competition. No. 5 - Could Oversold Leaning Technicals Suggest A Healthy Reversal Is Nearing? But more on those in a second... Germany: Cann-a-bis Shops To Open This Year? (2) Germany's government is advancing its CB LGLization efforts by planning municipal five-year pilot programs for state-regulated MJ sales in licensed shops. Since April 1st, Germany has LGLized adult-use CB, joining Malta and Luxembourg in the EU. Adults over 18 can possess up to 25 grams of dried CB flower. The Ministry of Agriculture is preparing to establish CB shops, focusing on scientific purposes and regulation. United Kingdom: Expected Medical MJ Sales To Surge The UK's medical MJ market is booming. In fact, there are higher than expected sales due to high per-patient consumption, according to Prohibition Partners. The report predicts that by the end of 2024, 62,960 patients will generate 240Mn eu.ros ($258.8Mn) in sales, with an average annual consumption of 3,811 eu.ros per patient. Jonathan Hodgson, CEO of Curaleaf Laboratories, was reported as commenting: "The beginning of 2024 has already shown a tremendous level of growth, with a record number of UK private clinics now providing medical CB treatment for lower appointment costs than ever before. More formulations and dosage forms have entered the market, such as pastilles and liquid va-pe cartridges, broadening the treatment options available for specialists to prescribe for patients." ----- Seed-To-Patient: Akanda Helps International Patients With Unmet Medical Needs Akanda has multiple gateways to international markets for EU GMP medical CB.

Holigen Global Health Holigen Premium European Cultivator Akanda owns a one-of-a-kind CB operation in Portugal - Holigen. Holigen consists of a high-quality 20,000 square foot indoor facility located near Lisbon (in Sintra) dedicated to the cultivation of high-T-H-C premium CB, one of a limited number of fully certified EU GMP of its kind in Europe, as well as a large seven million square foot (180+ acres) outdoor facility located two hours south in Aljustrel. Combined, these facilities provide the flexibility of capacity in Portugal to produce two tonnes of 1P premium indoor CB, over 100 tonnes of 1P outdoor CB, and over eight tonnes of 3P manufacturing capacity annually. Cansativa Group European Distribution - Cansativa European Distributor Akanda Corp. and Cansativa GmbH have a new cooperation that will allow German pharmacies to provide patients with two novel CB cultivars. This collaboration allows the Cansativa platform to supply the German market with dried flowers from Akanda's EU-GMP certified indoor grow facility in Sintra, Portugal. Akanda is expected to deliver at least 1,000 kilograms to Cansativa over the first 12-month term of the agreement. CanMart UK Based Distribution - CanMart UK Distributor Akanda's wholly owned subsidiary CanMart Ltd. is one of a limited number of fully licensed UK importers and wholesalers of medical CB to patients in the UK. CanMart provides route to market for CB grown at Bophelo's campus in Lesotho as well as an independent "open marketplace" supply chain solution into the UK for registered global CB companies looking to enter the European market. Cellen UK Patient Access - Cellen/Leva UK Clinic Akanda is partnered with UK digital healthcare leader Cellen and its fully integrated pain service to provide access to CB based medication for patients in need. Cellen's Leva Clinic (CQC registered) is the first fully online clinic for patients with chronic pain partnered with the NHS and Boots. Leva's multidisciplinary clinical team comprises expert clinicians, clinical psychologists, physiotherapists and nurse consultants. The team supports patients through personalized online care plans. Grab More Key Details Here: Akanda's Wesbite. ----- As mentioned above, AKAN has several key potential catalysts to keep a close eye on. Check them out: No. 1 AKAN Potential Catalyst - A Crazy Low Float Could Lead To Explosive Volatility! According to info pulled from Yahoo Finance's website, AKAN has a minuscule float. The website reports this profile to have roughly 782.54Mn shares in its float. Why is that figure important? It's important on one crucial level. Volatility. Could more positive company news in mid-2024 provide a near term spark? ----- No. 2 AKAN Potential Catalyst - Akanda Continues To Execute Strategic Initiative By Obtaining Key Canadian Cultivation License. Akanda Corp. Secures Hemp Cultivation License in Canada, Building on Previous Development Agreement London, United Kingdom--(Newsfile Corp. - September 16, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company") is excited to announce that it has obtained a license for hemp cultivation in Canada. This license is directly tied to Akanda's previously announced agreement with 1107385 B.C. LTD, further advancing the company's strategic initiatives in the Canadian CB market. This latest development highlights Akanda's commitment to executing its strategic vision and solidifying its role as a leader in the global CB industry. Read the full article here. ----- No. 3 AKAN Potential Catalyst - A First-Mover Attitude Could Propel AKAN To International Recognition. Akanda Corp. Announces Plans to Be Among International First Movers Pending Completion of Landmark Change in US Drug Policy London, United Kingdom--(Newsfile Corp. - May 10, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company")..., today announces it is actively following the landmark change in federal US policy to reschedule CB under the Controlled Substances Act ("CSA"). It has been widely reported that as of April 30, 2024 the DEA plans to reclassify CB as a Schedule III substance. The Company believes this imminent rescheduling may reinvigorate capital markets and could lead to changes in NASDAQ and NYSE rules on listing plant-touching U.S. companies. Should this occur and provided NASDAQ rule changes, Akanda has strategic plans to become a leader in consolidating US-based operators. ... Ms. Field commented, "Akanda's Board and Management have subject matter expertise in multiple global markets including the United States. We are closely monitoring the loosening of federal regulations and plan to explore US opp's. Some US markets are more depressed than others offering a unique opp. to capitalize on low entry prices of licenses or licensed operations." Read the full article here. ----- No. 4 AKAN Potential Catalyst - The Addition Of Block-chain And AI Solutions Could Separate AKAN From The Competition. Akanda Announces Plans to Enter Block-chain and AI Technology Sector London, United Kingdom--(Newsfile Corp. - April 12, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), ..., announces its plans to enter the block-chain and artificial intelligence sector of the CB industry. With an increasingly complex and global supply chain for the international CB industry, the Company believes companies and consumers will turn to block-chain and smart contracts to verify the authenticity of genetics, plants, and products alike. There are numerous advantageous applications of this technology such as harnessing block-chain capabilities to certify all clones, or baby plants, with a batch certificate. CB nurseries specialize in plant genetics, producing clones and baby plants and seeds for the purpose of wholesale distribution. Interim CEO and Director Katie Field commented, "Everyone from consumers, to growers, to manufacturers, to retailers care very much about the stages of production from seed to sale. We believe this technology can be used to verify the authenticity clones and genetic lineage." The Company believes other applications of block-chain include "track and trace" software for inventory and lab testing results. By utilizing this technology Certificate of Analyses (COAs) will be available at the end customer's fingertips to trace results back to the original laboratory. Block-chain technology provides traceability. Akanda believes Block-chain solutions will complement the artificial intelligence capability being developed at Canmart. Presently Canmart plans to partner with a platform developed by its directors to make medical CB more accessible to UK patients both with social shopping trends and tailored products. Access Kaneh utilizes an AI algorithm that analyzes DNA vis a vis products in the UK market. EndoDNA is a breakthrough test that matches patients with solutions for an individualized wellness journey. ... Ms. Field commented, "Akanda is competing in the brave new world of global CB and we intend to stay at the forefront of it by evaluating the technological solutions that can be leveraged in the business and scaled for our customers and end users. We are excited at the prospect to adopt cutting-edge technology that is a game-changer for companies and consumers alike." ... Read the full article here. ----- No. 5 AKAN Potential Catalyst - Could Oversold Leaning Technicals Suggest A Healthy Reversal Is Nearing? Here's what was cooking at 2:00PM EST on Thursday. Barchart was reporting multiple oversold technical indicators for AKAN. These technicals could be signaling a healthy reversal to be approaching in the near term. Here's the definition of a "reversal" from Investopedia: "A reversal is a change in the price direction of an asset. A reversal can occur to the upside or downside. Following an uptrend, a reversal would be to the downside. Following a downtrend, a reversal would be to the upside. Reversals are based on overall price direction and are not typically based on one or two periods/bars on a chart." Here are the technicals to pay close attention to (as of 2:00PM EST Thursday): 9-Day Relative Strength Index: 36.94% 14-Day Relative Strength Index: 37.91% When these numbers drop down to the 30% range and lower, they can be viewed as being in oversold territory. While in this territory, they can paint the picture of a profile that is undervalued. 14-Day Raw Stochastic: 17.65% 14-Day Williams %R: 82.35% As the Raw Stochastic nears the 10% range and lower and the Williams %R nears the 90% range or higher, these technical indicators may also be viewed as oversold and undervalued. Keep an eye on these technicals closely. ----- (Nasdaq: AKAN) Recap - 5 Potential Breakout Catalysts To Know Right Now! No. 1 - A Crazy Low Float Could Lead To Explosive Volatility! No. 2 - Akanda Continues To Execute Strategic Initiative By Obtaining Key Canadian Cultivation License. No. 3 - A First-Mover Attitude Could Propel AKAN To International Recognition. No. 4 - The Addition Of Block-chain And AI Solutions Could Separate AKAN From The Competition. No. 5 - Could Oversold Leaning Technicals Suggest A Healthy Reversal Is Nearing? ----- Coverage is officially initiated on (Nasdaq: AKAN). I'll be in touch with updates when necessary. Sincerely, Kai Parker StockWireNews Source 1 Source 2 (Always Remember The St-ock Prices Could Be Significantly Lower Now From The Dates I Provided.)

StockWireNews (stockwirenews . com) is owned by SWN Media LLC, a limited liability company. Data is provided from third-party sources and StockWireNews ("SWN") is not responsible for its accuracy. Make sure to always do your own research and due diligence on any day and swing profile I bring to your attention. Any emojis used do not have a specific defined meaning, and may be used inconsistently. We do not provide personalized fin.ancial advice, are not finan.cial advisors, and our opinions are not suitable for all in.vest.ors. The single member of SWN Media LLC owns and operates smallcapfirm . com ("SCF"), owns and operates fierceinvestor . com ("FI"), and owns and operates stockstreetwire . com ("SSW"). From time to time, StockWireNews, SCF, FI, and/or SSW will publicly disseminate information about a company via website, email, SMS and other points of media. Pursuant to an agreement between SWN Media LLC and TD Media LLC, SWN Media LLC has been hired by TD Media LLC for a period beginning on 10/10/2024 and ending on 10/11/2024 to publicly disseminate information about (AKAN:US) via digital communications. SWN Media LLC has been paid seventeen thousand five hundred USD ("Funds") to disseminate information about (AKAN:US) via digital communications. These Funds were part of the funds that TD Media LLC received from a third party who does not own st.ock in the issuer. To date, SWN Media LLC has been paid a total of thirty-two thousand five hundred USD to disseminate information about (AKAN:US) via digital communications. Neither SWN Media LLC, TD Media LLC and their member own shares of (AKAN:US). Please see important disclosure information here: www.stockwirenews.net/disclosure The single member of SWN Media LLC is also the single member of TD Media LLC. Pursuant to an agreement between TD Media LLC and IR Agency LLC, TD Media LLC has been hired for a period beginning on 10/10/2024 and ending on 10/11/2024 to publicly disseminate information about (AKAN:US) via digital communications. Under this agreement, we have been paid seventy-five thousand USD ("Funds"). These Funds were part of the funds that TD Media LLC received from a third party who does not own stock in the issuer. https://lifewatermedia.com/akan-disclosure-5182/ Unsubscribe Stock Wire News 160 West Camino Real Unit 886 Boca Raton, Florida 33432 United States